Obesity, Epidemiology and Risk

Sponsored by: Novo Nordisk

This resource will assess your knowledge of the epidemiology and comorbidities of obesity. You'll receive 1 hour of CPD on successful completion of this resource.
Novo Nordisk Logo

Resource Overview

The prevalence of obesity has increased sharply amongst developing and developed nations such that it now represents a global pandemic. Due to the associated co-morbidities of Diabetes, Cardiovascular Disease, Arthritis and Cancer, this represents not just a threat to wellbeing but also poses a financial threat to fragile healthcare systems.

Furthermore, the world has woken up to the fact that obesity has been recognised as a risk factor for a worse prognosis with COVID-19 infection. This module explores the pathophysiology of weight gain, control of appetite and also the related co-morbidities.

Aims and Objectives

On completion of this resource, you should have:

  • Improved understanding of the regulation of appetite and potential therapeutic targets
  • Critical understanding of the comorbidities that associate with weight gain